If you have been reading about Research chemical and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-12-11. Numbers and descriptions here follow the published literature rather than marketing material.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516, GW-501516, GW 501516, endurobol | Names vary in research and anti-doping documents. |
| Chemical class | Synthetic PPARδ agonist | Small-molecule nuclear receptor ligand. |
| CAS Registry Number | 317318-70-0 | Identifier commonly associated with GW501516. |
| Appearance | White to off-white powder | Typical for purified research material. |
| Solubility | Low in water; soluble in DMSO and ethanol | Organic solvents are common for laboratory stock solutions. |
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Diabetic retinopathy, caused by alterations in retinal microcirculation, leading to the growth of friable and poor-quality new blood vessels in the retina or capillary closure which causes ischemia or extravasation of intravascular content, causing edema (swelling of the macula). Retinopathy is the most common cause of blindness among non-elderly adults in the developed world. Diabetic nephropathy, damage to the kidney due to increased glomerular pressure and hyperfiltration can lead to end-stage chronic kidney disease that may require renal dialysis. In most parts of the world, diabetes mellitus is the leading cause of end-stage kidney disease (ESKD). Diabetic nephropathy is increasingly recognized as a significant cause of ESKD in renal allograft recipients. Diabetic neuropathy, Neuropathies in diabetes may cause sensory, mononeuritis, and autonomic neuropathy symptoms, muscle weakness, and potentially life-threatening complications like diabetic foot syndrome (Diabetic amyotrophy) and myocardial infarctions. Intensive insulin therapy is recommended to reduce neuropathy risk, while oral antidiabetic drugs are recommended for pain treatment. Diabetic encephalopathy, Diabetes causes brain functional and structural disturbances, known as diabetic encephalopathy. Various mechanisms are proposed, like alterations to the vascular supply of the brain, or changes in cerebral function and structure, including cognitive impairment, cerebral signal conduction, neurotransmission, and synaptic plasticity are more insidious.
The East Central Conference was founded in 1970 by eight medium-sized high schools in east central Wisconsin. Six of the eight schools were displaced by the dissolution of their previous conferences: three from the Little Nine Conference (Hortonville, Omro and Winneconne), two from the Little Ten Conference (Berlin and Ripon) and New London of the Mid-Eastern Conference. Former Central Wisconsin Conference members Waupaca and Weyauwega rounded out the original eight. In 1973, Weyauwega left the East Central Conference to rejoin the CWC, and Little Chute joined from the CWC as their replacement the following year. In 1979, New London exited for membership in the Bay Conference with Wautoma moving over from the CWC to maintain an eight-member conference. Aside from Waupun replacing Wautoma as a football-only member in 1995, the all-sport membership roster would remain intact for the next twenty years. In 1999, Hortonville, Little Chute and Waupaca became charter members of the Valley 8 Conference. Laconia and Markesan joined the ECC from the neighboring Flyway Conference to take the vacated members' place. For football, the two new members stayed in the Flyway Conference, with Mayville and St. Mary's Springs in Fond du Lac joining as football-only members. Two years later, the seven schools of the East Central Conference merged with the nine members of the Flyway Conference to form the East Central Flyway Conference.
== Personal life == Prior to moving to Los Angeles, Johnny was employed as a Manager at Microsoft in Chicago, Illinois. He is an avid golfer and won The Golf Channel's 2006 The Big-Break All Star Challenge Scrubs competition, beating out Robert Maschio ("The Todd") in the final match. While attending law school at the University of Iowa, he worked as a law clerk at the U.S. Attorney's Office. He practiced law in Chicago, Illinois, at the law firms of Katten Muchin Rosenman and Dentons before becoming a Founding Member (and VP of Business Development and Strategic Partnerships) of Acorn Finance.
Sources: en.wikipedia.org
AMS counts the atoms of 14C and 12C in a given sample, determining the 14C/12C ratio directly. The sample, often in the form of graphite, is made to emit C− ions (carbon atoms with a single negative charge), which are injected into an accelerator. The ions are accelerated and passed through a stripper, which removes several electrons so that the ions emerge with a positive charge. The ions, which may have from 1 to 4 positive charges (C+ to C4+), depending on the accelerator design, are then passed through a magnet that curves their path; the heavier ions are curved less than the lighter ones, so the different isotopes emerge as separate streams of ions. A particle detector then records the number of ions detected in the 14C stream, but since the volume of 12C (and 13C, needed for calibration) is too great for individual ion detection, counts are determined by measuring the electric current created in a Faraday cup. The large positive charge induced by the stripper forces molecules such as 13CH, which has a weight close enough to 14C to interfere with the measurements, to dissociate, so they are not detected. Most AMS machines also measure the sample's δ13C, for use in calculating the sample's radiocarbon age. The use of AMS, as opposed to simpler forms of mass spectrometry, is necessary because of the need to distinguish the carbon isotopes from other atoms or molecules that are very close in mass, such as 14N and 13CH. As with beta counting, both blank samples and standard samples are used.
"Mr Pace said the Ministry of the Interior was 'acting as a rogue element within the government'. It was controlled by the main Shia party, the Supreme Council for Islamic Revolution in Iraq (SCIRI); the Interior Minister, Baqir Jabr al-Zubeidi, is a former leader of SCIRI's Badr Brigade militia, which was one of the main groups accused of carrying out sectarian killings. Another was the Mahdi Army of the young cleric Muqtada al-Sadr, who is now part of the Shia coalition seeking to form a government after winning the mid-December election. Many of the 110,000 policemen and police commandos under the ministry's control are suspected of being former members of the Badr Brigade. Not only counterinsurgency units such as the Wolf Brigade, the Scorpions, and the Tigers, but the commandos and even the highway patrol police were accused of acting as death squads during this period over a decade ago.
At the beginning of July 2024, Santiago Peña expressed his opposition to the flexibilization of Mercosur, arguing that it is more advantageous to negotiate as a bloc, and questioned Uruguay's position of moving forward with bilateral agreements. Although in the first days of his term he had shown a willingness toward extra-bloc agreements, at that time he adopted the opposite stance. Prior to the transfer of the rotating presidency of Mercosur to Uruguay, Peña pointed to the need to continue efforts to strengthen regional integration, acknowledging that the bloc is going through a period of challenges. In October 2024, Peña lowered expectations regarding an imminent trade agreement between Mercosur and the European Union, underscoring that, although the bloc has shown interest in moving toward a free trade agreement, it has not found an equivalent willingness in Europe. He described as "unacceptable" the lack of recognition by Brussels of Paraguay's sanitary certification institutions. In December of that same year, he aligned himself with the position of the president of Brazil, Luiz Inácio Lula da Silva, reaffirming that Paraguay will not support unilateral negotiations that could fragment Mercosur's cohesion.
Sources: en.wikipedia.org
== Commercial syntheses of amino acids == Several methods exist to synthesize amino acids aside from the Strecker synthesis. The commercial production of amino acids, however, usually relies on mutant bacteria that overproduce individual amino acids using glucose as a carbon source. Otherwise amino acids are produced by enzymatic conversions of synthetic intermediates. 2-Aminothiazoline-4-carboxylic acid is an intermediate in one industrial synthesis of L-cysteine. Aspartic acid is produced by the addition of ammonia to fumarate using a lyase.
denotes contact. The second assumption in contact mechanics is related to the fact, that no tension force is allowed to occur within the contact area (contacting bodies can be lifted up without adhesion forces). This leads to an inequality which the stresses have to obey at the contact interface. It is formulated for the normal stress
=== Distribution === These proteins, which typically contain 2-4 repeats of the β-thymosin sequence, are found in all phyla of the animal kingdom, with the probable exception of sponges The sole mammalian example, a dimer in mice, is synthesised by transcriptional read-through between two copies of the mouse β15 gene, each of which is also transcribed separately. A uniquely multiple example is the protein thypedin of Hydra which has 27 repeats of a β-thymosin sequence.
Microgravity is the condition of low gravity found in outer space. Some of the major physiological implications that are associated with microgravity are bone loss, immunosuppression, enlargement of bones, muscle loss and movement of body fluids towards the head, spaceflight osteopenia, decrease in the function of cardiovascular system functions, decreased production of red blood cells, balance disorders, and also weaken the human immune system. In addition to this, fluid distribution is increased in the upper body due to the body's ability to pump blood faster to the upper body in microgravity conditions, known as the cephalad fluid shift. In addition, muscle regeneration protein levels have been estimated to vary due to microgravity conditions, including myostatin, activin A, and certain cytokines (e.g. IL-6, IL-10, IL-1ra), which are currently used as targets for drug delivery applications. The effects of microgravity has also investigated in wound healing processes, especially with the behavior of cell populations, such as fibroblasts. For cell studies, a Rotary Cell Culture System was used to mimic cell conditions in microgravity, where the bioreactor rotates horizontally, causing cell sedimentation in the vessel to be offset by the rotating fluid. This results in this light falling of cells, simulated in a microgravity environment. Studies showed a rearrangement of microtubules in cells due to microgravity, forming a dense, puzzled, network, unlike fibroblasts in a normal environment, which exhibit radial parallel formations.
Sources: en.wikipedia.org
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.
No. Cardarine is not a steroid hormone; it targets the nuclear receptor PPARδ. Its classification in anti-doping rules differs from anabolic steroids, though it remains prohibited in sport.
Early rodent studies reported tumor formation at multiple sites, which raised safety concerns. Sponsors stopped clinical development, and no approved human product exists.
LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.